Applied Therapeutics Inc (APLT) News

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces...

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLT

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Applied Therapeutics Reports Third Quarter 2024 Financial Results

- NDA and MAA for govorestat for treatment of Classic Galactosemia under FDA Priority Review and EMA review;...

Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage...